BioNotebook: Gates Foundation, Halozyme/Intrexon, Onconova, Spectrum, AnaptysBio/Momenta
This article was originally published in Scrip
Executive Summary
Gates Foundation names UCSF chancellor as CEO; Onyx's Torley replaces outgoing Halozyme CEO Frost; OncoNova falls 20% on Phase III rigosertib failure; Spectrum offers $100m in notes; and AnaptysBio, Momenta sign antibody deal.